welcome
Investor's Business Daily

Investor's Business Daily

Business

Business & Economics

Tandem Diabetes shares plunge 32% after the insulin pump maker issues light sales guidance

Investor's Business Daily
Summary
Nutrition label

77% Informative

Insulin pump maker Tandem Diabetes issues light sales guidance for 2025 .

For the year , the company expects $997 million to $1.007 billion in sales.

The high end of Tandem 's outlook missed analysts' forecast for $1 billion , according to FactSet .

At least six analysts cut their price targets on the insulin pump maker.

VR Score

84

Informative language

92

Neutral language

25

Article tone

formal

Language

English

Language complexity

34

Offensive language

not offensive

Hate speech

not hateful

Attention-grabbing headline

detected

Known propaganda techniques

not detected

Time-value

short-lived

Affiliate links

no affiliate links